Active ingredients
Pharmacological Group
Used in the treatment of
- T50.9.0* Alkaloid poisoning
- T46.0 Poisoning, cardiac-stimulant glycosides and drugs of similar action
- T30 Burn and corrosion, body region unspecified
- R14 Flatulence and related conditions
- N18 Chronic kidney disease
- L20 Atopic dermatitis
- K94* Diagnosis of gastrointestinal diseases
- K74.6 Other and unspecified cirrhosis of liver
- K59.1 Functional diarrhoea
- K31.8.2* Hyperacidity of gastric juice
- K30 Functional dyspepsia
- J45 Asthma
- E80.6 Other disorders of bilirubin metabolism
- B19 Unspecified viral hepatitis
- B18.9 Chronic viral hepatitis, unspecified
- A09 Other gastroenteritis and colitis of infectious and unspecified origin
- A05.9 Bacterial foodborne intoxication, unspecified
- A02.0 Salmonella enteritis
- A02 Other salmonella infections
- T56 Toxic effect of metals
- T78.4 Allergy, unspecified
- T51-T65 Toxic effect of substances, mainly non-medical
- T43 Poisoning by psychotropic drugs, not elsewhere classified
- E88.9 Metabolic disorder, unspecified
- B15-B19 Viral hepatitis